Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 known ✓ | O95136 | 5/20 | 0.40 |
| ▸ | S1PR4 known ✓ | O95977 | 5/20 | 0.40 |
| ▸ | S1PR1 known ✓ | P21453 | 5/20 | 0.40 |
| ▸ | S1PR3 known ✓ | Q99500 | 5/20 | 0.40 |
| ▸ | S1PR5 known ✓ | Q9H228 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1334527 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| Hydrochloric Acid SCHEMBL1333772 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| Hydrochloric Acid SCHEMBL1819036 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| Hydrochloric Acid SCHEMBL1123540 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| Hydrochloric Acid SCHEMBL1333851 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| Hydrochloric Acid SCHEMBL4642409 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| Hydrochloric Acid SCHEMBL1335394 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| Hydrochloric Acid SCHEMBL1123187 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| Hydrochloric Acid SCHEMBL28613823 | 0.98 | LMNA (0.50) | ALDH1A1TSHRLMNAEPHX1S1PR2 | |
| SCHEMBL271359 | 0.98 | ALDH1A1 (0.54) | ALDH1A1TSHRLMNAEPHX1S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3368592-B1 | COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN | DOW TORAY CO LTD (JP) | 2025-12-03 | — | — | EP | claimed |
| US-8735618-B2 | Solvent-free organosilane quaternary ammonium compositions, method of making and use | RESOURCE DEVELOPMENT L.L.C. (US) | 2014-05-27 | — | — | US | claimed |
| EP-2566874-A2 | SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE | Resource Development L.L.C. (US) | 2013-03-13 | — | — | EP | claimed |
| US-20120125226-A1 | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use | RESOURCE DEVELOPMENT L.L.C. (US) | 2012-05-24 | — | — | US | claimed |
| US-20110271873-A1 | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use | Resource Development, LLC (US) | 2011-11-10 | — | — | US | claimed |
| WO-2011140451-A2 | SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE | RESOURCE DEVELOPMENT L.L.C. (US) | 2011-11-10 | — | — | WO | claimed |
| EP-4355830-B1 | COATING COMPOSITIONS, METHODS OF MAKING AND USING SAME | PERFECT CARBON LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-3368592-B1 | COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN | DOW TORAY CO LTD (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-20240309227-A1 | Coating Compositions, Methods of Making and Using Same | PERFECT CARBON LLC | 2024-09-19 | — | — | US | disclosed |
| EP-4355830-A1 | COATING COMPOSITIONS, METHODS OF MAKING AND USING SAME | Perfect Carbon LLC (US) | 2024-04-24 | — | — | EP | disclosed |
| EP-2566874-B1 | SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE | RESOURCE DEV LLC (US) | 2023-01-18 | — | — | EP | disclosed |
| WO-2022266545-A1 | COATING COMPOSITIONS, METHODS OF MAKING AND USING SAME | PERFECT CARBON LLC (US) | 2022-12-22 | — | — | WO | disclosed |
| CN-108137820-B | Cosmetic composition, cosmetic and external preparation for skin | 陶氏东丽株式会社 | 2022-05-27 | — | — | CN | disclosed |
| EP-3368592-A1 | COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN | Dow Corning Toray Co., Ltd. (JP) | 2018-09-05 | — | — | EP | disclosed |
| WO-2017073755-A1 | COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN | DOW CORNING TORAY CO., LTD. (JP) | 2017-05-04 | — | — | WO | disclosed |
| US-8735618-B2 | Solvent-free organosilane quaternary ammonium compositions, method of making and use | RESOURCE DEVELOPMENT L.L.C. (US) | 2014-05-27 | — | — | US | disclosed |
| EP-2566874-A2 | SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE | Resource Development L.L.C. (US) | 2013-03-13 | — | — | EP | disclosed |
| US-20120125226-A1 | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use | RESOURCE DEVELOPMENT L.L.C. (US) | 2012-05-24 | — | — | US | disclosed |
| WO-2011140451-A2 | SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE | RESOURCE DEVELOPMENT L.L.C. (US) | 2011-11-10 | — | — | WO | disclosed |
| US-20110271873-A1 | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use | Resource Development, LLC (US) | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120125226-A1 | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use | VDAC1, CUTA, HVCN1 | S1PR2 2897/4885S1PR4 2763/4885S1PR1 2220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.